Equity Details
Price & Market Data
Price: $0.191
Daily Change: -$0.00893 / 4.68%
Daily Range: $0.188 - $0.204
Market Cap: $35,190,606
Daily Volume: 139,580
Performance Metrics
1 Week: 12.93%
1 Month: 24.22%
3 Months: 13.31%
6 Months: 81.82%
1 Year: 34.59%
YTD: 9.89%
About Vaso Corporation (VASO)
Up-to-the-minute market analysis for Vaso Corporation (VASO). Current price: 0.191, daily change: -$0.00893 / 4.68%. Market cap: 35,190,606. Explore all available performance indicators.
Company Details
Employees: 282
Sector: Technology services
Industry: Information technology services
Country: United States
Details
Vaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. It operates in three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed healthcare software solutions, including diagnostic imaging applications; managed network infrastructure, such as routers, switches, and other equipment; managed network transport; and managed network security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare, Inc. (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging equipment and ultrasound systems, GEHC service agreements, GEHC training, and GEHC and third-party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices and software. This segment offers Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure signals, including cloud-based software and algorithm subscription services; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems for non-invasive and outpatient treatment of ischemic heart disease. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York.